The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 39, Issue 5, 2013, Pages 498-509

  Kovari E ^a   Herrmann, F R ^a   Hof, P R ^b   Bouras, C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid angiopathy; Cortical microinfarcts; Immunohistochemistry; Neuropathology; Vascular

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN INFARCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GERIATRIC PATIENT; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; OCCIPITAL CORTEX; PARIETAL CORTEX; PREVALENCE; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

ALZHEIMER'S DISEASE; AMYLOID ANGIOPATHY; CORTICAL MICROINFARCTS; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; VASCULAR;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; BRAIN INFARCTION; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; SEVERITY OF ILLNESS INDEX; TAU PROTEINS;

EID: 84880147437     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12003     Document Type: Article

References (71)

1. Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol (Berl) 2004; 107: 83-90
2. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002; 109: 813-836
3. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003; 62: 885-898
4. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (Berl) 2009; 118: 115-130
5. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, Frangione B. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002; 12: 343-357
6. Esiri MM, Wilcock GK. Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry 1986; 49: 1221-1226
7. Jellinger KA, Lauda F, Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 2007; 14: 923-928
8. Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 1981; 29: 151-157
9. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983; 14: 924-928
10. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991; 30: 637-649
11. Yamada M, Tsukagoshi H, Otomo E, Hayakawa M. Cerebral amyloid angiopathy in the aged. J Neurol 1987; 234: 371-376
12. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 1996; 46: 1592-1596
13. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Subpial β/A4 peptide deposits are closely associated with amyloid angiopathy in the elderly. Neurosci Lett 1993; 155: 144-147
14. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease - autopsy results in 150 cases. Ann Neurol 1988; 24: 50-56
15. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-175
16. Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease. Ann N Y Acad Sci 1997; 826: 493-497
17. Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2002; 61: 282-293
18. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311-324
19. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995; 52: 702-708
20. Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 2011; 7: 1-9
21. Richard E, Carrano A, Hoozemans JJ, van Horssen J, van Haastert ES, Eurelings LS, de Vries HE, Thal DR, Eikelenboom P, van Gool WA, Rozemuller AJ. Characteristics of dyshoric capillary cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2010; 69: 1158-1167
22. Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol 2008; 255: 70-76
23. Bergeron C, Ranalli PJ, Miceli PN. Amyloid angiopathy in Alzheimer's disease. Can J Neurol Sci 1987; 14: 564-569
24. Pantelakis S. Un type particuliar d'angiopathie sénile du système nerveux central: l'angiopathie congophile; topographie et fréquence [A particular type of senile angiopathy of the central nervous system: congophilic angiopathy; topography and frequency]. Monatsschr Psychiatr Neurol 1954; 128: 219-256
25. Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol (Berl) 2005; 110: 222-231
26. Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986; 45: 79-90
27. Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR. AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 2008; 29: 1587-1590
28. De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA, Pasquier F. The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 2011; 18: 913-918
29. De Reuck J, Deramecourt V, Cordonnier C, Leys D, Pasquier F, Maurage CA. Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study. J Neurol Sci 2011; 300: 63-66
30. Haglund M, Passant U, Sjobeck M, Ghebremedhin E, Englund E. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 2006; 21: 681-687
31. Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, Greenberg SM. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009; 72: 1230-1235
32. Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol 2000; 57: 869-874
33. Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Ann N Y Acad Sci 2000; 903: 138-143
34. Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, Vinters HV. Cerebral microinfarcts associated with severe cerebral β-amyloid angiopathy. Brain Pathol 2010; 20: 459-467
35. Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology 2011; 77: 48-54
36. Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol (Berl) 1992; 83: 170-178
37. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259
38. Thal DR, Rüb U, Orantes M, Braak H. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791-1800
39. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, Bouras C, Giannakopoulos P. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004; 35: 410-414
40. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab 2012; 32: 425-436
41. Okamoto Y, Ihara M, Fujita Y, Ito H, Takahashi R, Tomimoto H. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport 2009; 20: 990-996
42. Ishihara T, Takahashi M, Yokota T, Yamashita Y, Gondo T, Uchino F, Iwamoto N. The significance of cerebrovascular amyloid in the etiology of superficial (lobar) cerebral-hemorrhage and its incidence in the elderly population. J Pathol 1991; 165: 229-234
43. Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 2007; 257: 49-55
44. Haglund M, Sjobeck M, Englund E. Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Dement Geriatr Cogn Disord 2004; 18: 132-137
45. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, Kitamura A, Washida K, Yamada M, Ito H, Tomimoto H, Takahashi R, Ihara M. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol (Berl) 2012; 123: 381-394
46. Scholz W. Studien zur Pathologie der Hirngefässe II. Die drüsige Entartung der Hirnarterien und Capillaren. Z Gesamte Neurol Psychiatr 1938; 162: 694-715
47. Grégoretti L. Contribution à l'étude des foyers cicatriciels de nécrose parenchymateuse élective de l'écorce cérébrale occipitale et préfrontale [Cicatricial foci of elective parenchymatous necrosis of the occipital and prefrontal cortex]. Rev Neurol 1956; 95: 207-217
48. Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA. Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain. Brain 2008; 131: 3299-3310
49. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996; 72: 193-214
50. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998; 153: 725-733
51. Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. Cerebrovascular disease is a major factor in the failure of elimination of Aβ from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci 2002; 977: 162-168
52. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG. Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 1995; 270: 7013-7016
53. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995; 37: 294-299
54. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 1994; 13: 45-53
55. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Full-length amyloid-β (1-42(43)) and amino-terminally modified and truncated amyloid-β 42(43) deposit in diffuse plaques. Am J Pathol 1996; 149: 1823-1830
56. Love S. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1-4
57. Mak K, Yang F, Vinters HV, Frautschy SA, Cole GM. Polyclonals to β-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res 1994; 667: 138-142
58. Mann DM, Iwatsubo T. Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid β protein (Aβ) only in the form of Aβ42(43). Neurodegeneration 1996; 5: 115-120
59. Mann DM, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman ML, Rossor MN. Predominant deposition of amyloid-β 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996; 148: 1257-1266
60. Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S. Dominant and differential deposition of distinct β-amyloid peptide species, Aβ N3(pE), in senile plaques. Neuron 1995; 14: 457-466
61. Armstrong RA, Myers D, Smith CU. The ratio of diffuse to mature β/A4 deposits in Alzheimer's disease varies in cases with and without pronounced congophilic angiopathy. Dementia 1993; 4: 251-255
62. Lippa CF, Hamos JE, Smith TW, Pulaski-Salo D, Drachman DA. Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. Arch Neurol 1993; 50: 1088-1092
63. Rozemuller AJ, Roos RA, Bots GT, Kamphorst W, Eikelenboom P, Van Nostrand WE. Distribution of β/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol 1993; 142: 1449-1457
64. Tian J, Shi J, Bailey K, Mann DM. Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease. Neurosci Lett 2003; 352: 137-140
65. Wisniewski HM, Wegiel J. β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 1994; 87: 233-241
66. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 1995; 65: 931-934
67. Frackowiak J, Mazur-Kolecka B, Wisniewski HM, Potempska A, Carroll RT, Emmerling MR, Kim KS. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 1995; 676: 225-230
68. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993; 623: 142-146
69. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75-80
70. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 2007; 68: 927-931
71. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 2002; 977: 9-23